Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s515930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Chunmei Xiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bone Metabolism, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of C…. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis, NF-kappa B p50 Subunit, Bone Resorption. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Bone Metabolism, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of China.
- Department of Clinical Medicine, Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, 310015, People's Republic of China.
- Orthopedic Department, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of China.
- General Surgical Department, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of China.
- Department of Nursing, Zhejiang University School of Medicine First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, People's Republic of China.
ORCID-Profile: Dun Hong, Liwei Zhang
Zitieren
APA
Xiu, C., Luo, H., Huang, W., Fan, S., Yuan, C., Chen, J., Xu, C., Yao, C., Hong, D., & Zhang, L. (2025). Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s515930
Vancouver
Xiu C, Luo H, Huang W, Fan S, Yuan C, Chen J, et al. Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s515930
BibTeX
@article{Xiu2025,
author = {Xiu, Chunmei and Luo, Hua and Huang, Weixing and Fan, Shaohua and Yuan, Chiting and Chen, Jiangjie and Xu, Chenghao and Yao, Can and Hong, Dun and Zhang, Liwei},
title = {Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s515930}
}
EUVIMED